352 related articles for article (PubMed ID: 10861571)
1. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
[TBL] [Abstract][Full Text] [Related]
2. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
3. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
4. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
7. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
8. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
9. p53 expression in oral cancer: observations of a South Indian study.
Pillay M; Vasudevan DM; Rao CP; Vidya M
J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
[TBL] [Abstract][Full Text] [Related]
12. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
13. Expression of p63 protein and mRNA in oral epithelial dysplasia.
Chen YK; Hsue SS; Lin LM
J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
[TBL] [Abstract][Full Text] [Related]
14. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
16. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
de Oliveira LR; Ribeiro-Silva A; Zucoloto S
J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
[TBL] [Abstract][Full Text] [Related]
18. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
20. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma.
Kusama K; Okutsu S; Takeda A; Himiya T; Kojima A; Kidokoro Y; Chu L; Iwanari S; Kudo I; Moro I
J Pathol; 1996 Apr; 178(4):415-21. PubMed ID: 8691320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
